Lesion Stiffness Measured by Magnetic Resonance Elastography: A Novel Biomarker for Differentiating Benign, Premalignant and Malignant Prostate Lesions
Prospective study evaluates magnetic resonance elastography for differentiating benign, premalignant, and malignant prostate lesions, suggesting diagnostic utility.
Key Points
Lesion stiffness effectively distinguishes benign, premalignant, and malignant prostate lesions with high accuracy.
Mean central gland stiffness shows significant differences, with malignant lesions exhibiting the highest stiffness (3.6 kPa).
Lesion stiffness measurement has superior diagnostic accuracy in differentiating benign from premalignant lesions (AUC 0.82).
Magnetic resonance elastography-derived metrics may enhance multiparametric imaging approaches for prostate assessment.